ArticlePharmaceuticals (Basel, Switzerland)2023

Morin Sensitizes MDA-MB-231 Triple-Negative Breast Cancer Cells to Doxorubicin Cytotoxicity by Suppressing FOXM1 and Attenuating EGFR/STAT3 Signaling Pathways.

Sushma Maharjan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.